# Alexza Pharmaceuticals, Inc. – FDA Inspection, Sep 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/316cd956-10ab-4ffb-937c-3b3bba844f2b
Source feed: FDA_Inspections

> FDA inspection 1109014 of Alexza Pharmaceuticals, Inc., September 26, 2019. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1109014
- Company Name: Alexza Pharmaceuticals, Inc.
- Inspection Date: 2019-09-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1300206 - 2025-12-19
- [FDA Inspection 1281572 - 2025-08-01](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/8e1f7e72-88f4-4c2e-940e-2279b9592391)
- FDA Inspection 1227246 - 2023-12-22
- [FDA Inspection 926541 - 2015-05-21](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/807afa89-bcab-457f-8c8f-51714e067230)
- FDA Inspection 866702 - 2014-02-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)

Company: https://www.keypedia.com/companies/alexza-pharmaceuticals-inc/4b71680e-1a0e-4237-8b2a-2e2c32c5c8fe

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c